Opendata, web and dolomites

PERFORM SIGNED

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "PERFORM" data sheet

The following table provides information about the project.

Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE 

Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ
website: http://www.imperial.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.perform2020.org
 Total cost 18˙467˙697 €
 EC max contribution 17˙997˙665 € (97%)
 Programme 1. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-PHC-2015-two-stage
 Funding Scheme RIA
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2020-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) coordinator 6˙373˙692.00
2    STICHTING KATHOLIEKE UNIVERSITEIT NL (NIJMEGEN) participant 1˙500˙000.00
3    LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER UK (LONDON) participant 1˙385˙703.00
4    SERVIZO GALEGO DE SAUDE ES (Santiago de Compostela) participant 1˙004˙250.00
5    THE UNIVERSITY OF LIVERPOOL UK (LIVERPOOL) participant 989˙471.00
6    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM NL (ROTTERDAM) participant 970˙386.00
7    MEDIZINISCHE UNIVERSITAT GRAZ AT (GRAZ) participant 899˙500.00
8    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 799˙937.00
9    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 746˙450.00
10    UNIVERSITY OF NEWCASTLE UPON TYNE UK (NEWCASTLE UPON TYNE) participant 700˙743.00
11    UNITED KINGDOM RESEARCH AND INNOVATION UK (SWINDON) participant 570˙000.00
12    BIOMERIEUX SA FR (Marcy l'Etoile) participant 400˙100.00
13    MICROPATHOLOGY LIMITED UK (COVENTRY) participant 358˙681.00
14    ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON EL (ATHINA) participant 350˙000.00
15    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) participant 350˙000.00
16    RIGAS STRADINA UNIVERSITATE LV (RIGA) participant 299˙375.00
17    UNIVERZITETNI KLINICNI CENTER LJUBLJANA SI (LJUBLJANA) participant 299˙375.00
18    MEDICAL RESEARCH COUNCIL UK (SWINDON) participant 0.00
19    UNIVERSITAET BERN CH (BERN) participant 0.00

Map

 Project objective

The management of febrile patients is one of the most common and important problems facing healthcare providers. Distinction between bacterial infections and trivial viral infection on clinical grounds is unreliable, and as a result innumerable patients worldwide undergo hospitalization, invasive investigation and are treated with antibiotics for presumed bacterial infection when, in fact, they are suffering from self-resolving viral infection. We aim to improve diagnosis and management of febrile patients, by application of sophisticated phenotypic, transcriptomic (genomic, proteomic) and bioinformatic approaches to well characterised large-scale, multi-national patient cohorts already recruited with EU funding. We will identify, and validate promising new discriminators of bacterial and viral infection including transcriptomic and clinical phenotypic markers. The most accurate markers distinguishing bacterial and viral infection will be evaluated in prospective cohorts of patients reflecting the different health care settings across European countries. By linking sophisticated new genomic and proteomic approaches to careful clinical phenotyping, and building on pilot data from our previous studies we will develop a comprehensive management plan for febrile patients which can be rolled out in healthcare systems across Europe.

 Deliverables

List of deliverables.
Consent and Child Assent Forms Documents, reports 2019-09-02 14:30:29
Project Handbook Documents, reports 2019-09-02 14:30:29
Transcriptomic and proteomic signatures of bacterial and viral infections Documents, reports 2019-09-02 14:30:29
PERFORM Website Websites, patent fillings, videos etc. 2019-09-02 14:30:29
PERFORM Dissemination & Communnication Strategy Documents, reports 2019-09-02 14:30:29
report on molecular diagnostics Documents, reports 2019-09-02 14:30:29
Clinical Recruitment & Data Collection Documents Documents, reports 2019-09-02 14:30:29
All Approvals Package Documents, reports 2019-09-02 14:30:29
1st Annual Meeting Report Documents, reports 2019-09-02 14:30:29
Tool-server Platforms Documents, reports 2019-09-02 14:30:29
Provider, Parent and Costing Studies Documents, reports 2019-09-02 14:30:29
Operational Database Documents, reports 2019-09-02 14:30:29
Mid-Term Recruitment Report Documents, reports 2019-09-02 14:30:29
Ethics Board Report (Preliminary) Documents, reports 2019-09-02 14:30:29
2nd Annual Meeting Report Documents, reports 2019-09-02 14:30:29
Ethics Review Report Documents, reports 2019-09-02 14:30:29

Take a look to the deliverables list in detail:  detailed list of PERFORM deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PERFORM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PERFORM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.6.)

EBRA (2018)

European Brain Research Area

Read More  

SAPHIRE (2018)

Securing Adoption of Personalised Health in REgions

Read More  

HTx (2019)

Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe

Read More